TP53 and breast cancer: For example, loss of p53 in breast cancer cells induces the secretion of WNT ligands, which stimulate tumor-associated macrophages (TAMs) to produce IL-1β, resulting in metastatic progression-potentiating systemic neutrophilic inflammation [33].